OFS Capital Corporation — Q3 2023 Form 10-Q Summary
Business context and reporting period
OFS Capital Corporation is an externally managed, non-diversified business development company and regulated investment company focused primarily on senior secured loans to middle-market and larger U.S. companies, with additional equity and structured finance investments. This unaudited Form 10-Q covers the three and nine months ended September 30, 2023.
Financial performance and position
| Metric | Q3 2023 | 9M 2023 |
|---|---|---|
| Total investment income | $14.7 million | $43.5 million |
| Net investment income | $5.4 million; $0.40/share | $15.5 million; $1.15/share |
| Net increase in net assets from operations | $1.8 million; $0.14/share | $3.6 million; $0.27/share |
| Net loss on investments | $3.4 million | $11.6 million |
| Distributions declared | $0.34/share | $1.00/share |
| Net asset value per share | $12.74 at September 30 | $13.47 at December 31, 2022 |
Q3 net investment income represented approximately 36.8% of total investment income. Total expenses were $9.3 million, including $4.9 million of interest expense, $1.8 million of management fees and $1.3 million of income incentive fees. The filing does not present a conventional operating margin.
Total assets were $477.0 million, including investments at fair value of $457.2 million and cash of $15.9 million. Total liabilities were $306.3 million and net assets were $170.7 million. The portfolio comprised $279.2 million of debt investments, $94.7 million of equity investments and $83.3 million of structured finance securities. Approximately 99% of the loan portfolio at fair value consisted of senior secured loans.
Nine-month operating cash flow was $47.0 million, compared with cash used in operations of $21.2 million in the prior-year period. Cash increased by $1.0 million to $15.9 million after $46.0 million of financing cash outflows, including $13.4 million of distributions, $13.6 million of revolving debt repayments and $19.0 million of SBA debenture repayments.
Total outstanding debt was approximately $303.0 million principal, consisting of $180.0 million of unsecured notes, $91.1 million under the BNP Facility and $31.9 million of SBA debentures. The PWB Credit Facility had no borrowings and $25.0 million of unused commitment; the BNP Facility had $58.9 million of unused commitment. Asset coverage was 163%, above the 150% regulatory minimum. Approximately 89% of debt matures in 2026 or later, 70% bears fixed rates and 59% is unsecured.
Material changes versus comparable periods
- Q3 net investment income increased to $5.4 million from $4.4 million in Q3 2022; nine-month NII increased to $15.5 million from $13.6 million.
- Q3 total investment income increased to $14.7 million from $13.4 million in Q3 2022. Nine-month investment income increased to $43.5 million from $34.7 million.
- Q3 results improved from a $9.6 million net loss in the prior-year quarter to a $1.8 million net increase in net assets, primarily because investment losses were less severe.
- Compared with December 31, 2022, fair value of investments declined $43.3 million, net assets declined $9.8 million and NAV per share declined from $13.47 to $12.74.
- Debt declined from approximately $331.9 million of principal at year-end 2022 to $303.0 million, primarily due to $19.0 million of SBA debenture repayments and lower BNP borrowings.
- Non-accrual loans increased to $16.7 million at fair value from $11.2 million at December 31, 2022; loans with $6.4 million of fair value were newly placed on non-accrual during Q3.
- Q3 weighted-average performing income yield increased to 14.6% from 13.8% in the prior quarter, partly due to non-recurring interest recognized on the payoff of a loan accumulation facility.
Outlook, commentary, risks and unusual items
Management stated that the balance sheet remained well positioned in the current interest-rate environment and that available liquidity was sufficient to support existing portfolio companies. The filing provides no formal earnings or distribution guidance; however, the Board declared a fourth-quarter 2023 distribution of $0.34 per share, payable December 29, 2023.
Management is continuing to emphasize first-lien senior secured loans to larger borrowers and is gradually repaying SBIC I LP’s SBA debentures. The portfolio had $14.1 million of unfunded commitments to nine portfolio companies. Approximately 94% of the loan portfolio at fair value bore floating rates, while the BNP Facility also carries a floating rate, exposing earnings to changes in SOFR and other rate indices.
Key risks include rising funding costs, borrower credit deterioration, non-accruals, valuation uncertainty, concentration in illiquid Level 3 investments, structured finance volatility, and potential market disruption from inflation, recession, geopolitical conflicts and banking-system instability. Pfanstiehl Holdings equity represented $77.1 million, or 16.9% of total portfolio fair value and 45.2% of net assets; most of its value consisted of unrealized appreciation, creating material NAV concentration risk.
The PWB Credit Facility matures February 28, 2024, and management stated that it is uncertain whether the facility can be extended or replaced following the announced Banc of California and Pacific Western Bank merger. The Company was in compliance with its debt covenants at September 30, 2023. No material pending legal proceedings or material changes to previously disclosed risk factors were reported.
Important facts for investors to verify
- Reconcile the $0.34 quarterly distribution with $0.40 of Q3 NII per share and assess the tax character of distributions, which is determined annually.
- Monitor the $16.7 million fair value of non-accrual loans and the $39.2 million amortized-cost balance, including recoveries and additional placements on non-accrual.
- Evaluate the sustainability of NAV given the $77.1 million Pfanstiehl equity valuation and its substantial unrealized appreciation.
- Assess refinancing and liquidity plans for the PWB Facility maturity, the $31.9 million of SBA debentures due in 2025 and other debt maturities.
- Review the sensitivity of NII and NAV to SOFR, credit spreads, defaults, recovery rates and fair-value assumptions; most investments are Level 3.
- Consider concentration risk: the ten largest portfolio-company investments represented 49.6% of portfolio fair value, while manufacturing, health care and wholesale trade represented approximately 61.4% of portfolio-company investments.
- Review related-party management and incentive fees, conflicts of interest and the fact that affiliates held approximately 22.5% of outstanding common stock.